NIH-funded research R21 grant

Investigating the endometrial-myometrial junction in adenomyosis to discover new treatments

Official title: Single cell analytics and drug discovery at the endometrial-myometrial junction in symptomatic adenomyosis

Funded at University of California, San Francisco · NIH-10871250 · Data updated 2026-11-12

This study is looking at adenomyosis, a painful condition that affects some women, to better understand how it works at a tiny level and to find new treatments that could help ease symptoms and improve daily life.

More Adenomyosis research and trials

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionUniversity of California, San Francisco
NIH-funded
Lab location1 site (San Francisco, United States)
Project startAugust 1, 2024
Project endJuly 31, 2026
Funding year2024
Award (this year)$337,926
NIH project number1R21HD114953-01
Project IDNIH-10871250 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are women diagnosed with adenomyosis who experience severe symptoms such as dysmenorrhea and heavy menstrual bleeding.

Less likely to help

Patients who do not have adenomyosis or those who have already undergone a hysterectomy may not benefit from this research.

What this research studies

This research focuses on adenomyosis, a painful uterine condition where endometrial cells invade the myometrium, causing inflammation and severe symptoms like heavy menstrual bleeding and dysmenorrhea. By examining these cells at a single-cell level, the research aims to understand the underlying mechanisms of the disease and identify potential new therapies. The approach includes advanced bioinformatics and drug discovery techniques to develop targeted treatments that could alleviate symptoms and improve the quality of life for affected women.

Why it matters

Potential benefit: If successful, this research could lead to innovative treatments that significantly reduce the symptoms of adenomyosis and enhance the well-being of patients.

How similar studies have gone: Previous research has shown promise in using single-cell analytics for understanding complex diseases, suggesting that this approach could yield valuable insights for adenomyosis.

Where this research is happening

  • University of California, San Francisco
    San Francisco, United States
    Active

Researchers

  • Principal investigator: Giudice, Linda C — University of California, San Francisco
  • Study coordinator: Giudice, Linda C

Related research

Other NIH-funded projects on the same topics.

  • Understanding how RPLP1 affects endometriosis and adenomyosis

    A patient-focused look at how a ribosomal protein called RPLP1 may drive tissue changes in endometriosis and adenomyosis and what this could mean for future therapies.

    NIH research University of Kansas Medical Center · Kansas City, United States · NIH-11434812

  • Understanding Adenomyosis at the Cellular Level to Find New Treatments

    This work aims to understand adenomyosis, a common uterine condition, by looking closely at individual cells to find new ways to help women with symptoms.

    NIH research University of California, San Francisco · San Francisco, United States · NIH-11141913

  • Understanding how ion channels affect uterine contractions and reproductive health

    This study is looking at how tiny channels in the muscle cells of the uterus work, which is important for things like your period and pregnancy, to better understand conditions like adenomyosis that can cause pain and trouble getting pregnant.

    NIH research Univ of Massachusetts Med Sch Worcester · Worcester, United States · NIH-11134072

  • Investigating the role of specific molecules in the development of adenomyosis.

    This study is looking into adenomyosis, a condition that causes pain and problems with pregnancy, to find out how certain molecules in the body affect it, which could help create new, less invasive treatments for those who suffer from it.

    NIH research University of Kansas Medical Center · Kansas City, United States · NIH-11085179

  • Cannabinoid-based product for gynecologic pain in endometriosis, adenomyosis, or PID

    This study tests a high-CBD, hemp-derived product against placebo in adults with gynecologic pain from endometriosis, adenomyosis, or PID over one week to see if it reduces pain and related symptoms.

    Recruiting Phase 1/2 Mclean Hospital · Belmont, Massachusetts · NCT07728695

  • Good pain consultation for endometriosis

    This trial will test whether adding a 'good pain consultation' with early biopsychosocial pain education to usual care helps biological women with endometriosis manage pain and improve quality of life.

    Recruiting Sorlandet Hospital HF · Kristiansand, Agder · NCT07205614

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.